NCCN Hodgkin Disease/Lymphoma Panel Members

These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. This manuscript is being updated to correspond with the newly updated algorithm. These guidelines are a statement of consensus of the authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these guidelines is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient's care or treatment. The National Comprehensive Cancer Network makes no representations nor warranties of any kind whatsoever regarding their content, use, or application and disclaims any responsibility for their application or use in any way. These guidelines are copyrighted by National Comprehensive Cancer Network. All rights reserved. These guidelines and the illustrations herein may not be reproduced in any form without the express written permission of NCCN. ©2007. · · For help using these documents, please click here Staging Manuscript References Clinical Trials: Categories of Consensus: NCCN All recommendations are Category 2A unless otherwise specified. See The believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged. NCCN To find clinical trials online at NCCN member institutions, click here: These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN.